Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

July 21, 2026 · Financial Post

Visit freshyourfeel.com for more information.

Asian Stocks Set for Gains as Chipmakers Rebound: Markets Wrap
Stocks in Asia were set to gain on Wednesday as a rebound in chipmakers at the center of the artificial intelligence boo
California Wildcatter PCEC Near Deal on Venezuela Oil Fields
Pacific Coast Energy Co., a small California producer, is nearing a deal to operate two Venezuelan oil fields as the US-
Moody’s Lifts Argentina Debt Rating in Fresh Boost to Milei
Moody’s Ratings upgraded Argentina’s credit score, giving the nation its third sovereign upgrade in less than three mont
Could Secret Harbour set the stage for Hanson’s greater ambitions?
In Perth, Pauline Hanson declared her interest in the top job and backed it up with a surprising restrained performance.
U.S. readies new tariffs on dozens of countries as Trump’s 10% global levy set to expire
Analysts expect that new planned tariffs, ostensibly over forced labor concerns, -- ranging between 10 per cent and 12.5